Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 32

1.

Alendronate for the treatment of osteoporosis in men.

Orwoll E, Ettinger M, Weiss S, Miller P, Kendler D, Graham J, Adami S, Weber K, Lorenc R, Pietschmann P, Vandormael K, Lombardi A.

N Engl J Med. 2000 Aug 31;343(9):604-10.

2.

Alendronate for the Treatment of Osteoporosis in Men: A Meta-Analysis of Randomized Controlled Trials.

Xu Z.

Am J Ther. 2017 Mar/Apr;24(2):e130-e138. doi: 10.1097/MJT.0000000000000446. Review.

PMID:
27058577
3.

[Measurement of bone mineral density is necessary for monitoring of bisphosphonate treatment].

Soen S.

Clin Calcium. 2011 Jan;21(1):116-9. doi: CliCa1101116119. Review. Japanese.

PMID:
21187604
4.

[Clinical trials of alendronate].

Okano T, Teshima R.

Nihon Rinsho. 2003 Feb;61(2):231-4. Review. Japanese.

PMID:
12638213
5.

[Evidence of alendronate treatment for osteoporosis].

Harada A.

Nihon Rinsho. 2007 Nov 28;65 Suppl 9:337-43. Review. Japanese. No abstract available.

PMID:
18161127
6.

Treatment of male osteoporosis: recent advances with alendronate.

Ringe JD, Orwoll E, Daifotis A, Lombardi A.

Osteoporos Int. 2002 Mar;13(3):195-9. Review.

PMID:
11991437
7.

Osteoporosis in men: a review of endogenous sex hormones and testosterone replacement therapy.

Martin AC.

J Pharm Pract. 2011 Jun;24(3):307-15. doi: 10.1177/0897190010397716. Epub 2011 Mar 24. Review.

PMID:
21676854
8.

[Alendronate in the treatment of osteoporosis].

Inaba M.

Nihon Rinsho. 2002 Mar;60 Suppl 3:373-80. Review. Japanese. No abstract available.

PMID:
11979932
9.

A risk-benefit assessment of alendronate in the treatment of involutional osteoporosis.

Devogelaer JP.

Drug Saf. 1998 Aug;19(2):141-54. Review.

PMID:
9704250
10.

[Bisphosphonates: pharmacology and use in the treatment of osteoporosis].

Kishimoto H.

Nihon Rinsho. 2002 Mar;60 Suppl 3:350-8. Review. Japanese. No abstract available.

PMID:
11979929
11.

Alendronate prevents glucocorticoid-induced osteoporosis in patients with rheumatic diseases: A meta-analysis.

Kan SL, Yuan ZF, Li Y, Ai J, Xu H, Sun JC, Feng SQ.

Medicine (Baltimore). 2016 Jun;95(25):e3990. doi: 10.1097/MD.0000000000003990. Review.

12.

[Osteoporosis in the aged male].

Szulc P, Delmas PD.

Presse Med. 2002 Nov 23;31(37 Pt 1):1760-9. Review. French.

PMID:
12489321
13.

[Treatment of osteoporosis combined with a bisphosphonate and vitamin D3].

Kobayashi S, Shiraki M, Takaoka K.

Nihon Rinsho. 2004 Feb;62 Suppl 2:461-5. Review. Japanese. No abstract available.

PMID:
15035171
14.

[Alendronate--a new drug for treatment of osteoporosis].

Pluskiewicz W, Drozdzowska B.

Chir Narzadow Ruchu Ortop Pol. 1997;62(1):73-7. Review. Polish.

PMID:
9198552
15.

[Treatment of male osteoporosis].

Iba K.

Nihon Rinsho. 2002 Mar;60 Suppl 3:306-14. Review. Japanese. No abstract available.

PMID:
11979923
16.

Eldecalcitol: a review of its use in the treatment of osteoporosis.

Sanford M, McCormack PL.

Drugs. 2011 Sep 10;71(13):1755-70. doi: 10.2165/11206790-000000000-00000. Review. Erratum in: Drugs. 2011 Dec 24;71(18):2390.

PMID:
21902297
17.

[Treatment of osteoporosis with alendronate].

Sohen S.

Nihon Rinsho. 2004 Feb;62 Suppl 2:415-8. Review. Japanese. No abstract available.

PMID:
15035162
18.

[Vitamin K2].

Shiraki M.

Nihon Rinsho. 1998 Jun;56(6):1525-30. Review. Japanese.

PMID:
9648476
19.

Male hypogonadism and skeletal health.

Irwig MS.

Curr Opin Endocrinol Diabetes Obes. 2013 Dec;20(6):517-22. doi: 10.1097/01.med.0000436185.36717.76. Review.

PMID:
24468754
20.

Testosterone use in men and its effects on bone health. A systematic review and meta-analysis of randomized placebo-controlled trials.

Tracz MJ, Sideras K, BoloƱa ER, Haddad RM, Kennedy CC, Uraga MV, Caples SM, Erwin PJ, Montori VM.

J Clin Endocrinol Metab. 2006 Jun;91(6):2011-6. Epub 2006 May 23. Review.

PMID:
16720668

Supplemental Content

Support Center